402 related articles for article (PubMed ID: 35907805)
1. Fn14 exacerbates acute lung injury by activating the NLRP3 inflammasome in mice.
Guan XX; Yang HH; Zhong WJ; Duan JX; Zhang CY; Jiang HL; Xiang Y; Zhou Y; Guan CX
Mol Med; 2022 Jul; 28(1):85. PubMed ID: 35907805
[TBL] [Abstract][Full Text] [Related]
2. Blocking triggering receptor expressed on myeloid cells-1 attenuates lipopolysaccharide-induced acute lung injury via inhibiting NLRP3 inflammasome activation.
Liu T; Zhou Y; Li P; Duan JX; Liu YP; Sun GY; Wan L; Dong L; Fang X; Jiang JX; Guan CX
Sci Rep; 2016 Dec; 6():39473. PubMed ID: 28004759
[TBL] [Abstract][Full Text] [Related]
3. Corticosteroids alleviate lipopolysaccharide-induced inflammation and lung injury via inhibiting NLRP3-inflammasome activation.
Yang JW; Mao B; Tao RJ; Fan LC; Lu HW; Ge BX; Xu JF
J Cell Mol Med; 2020 Nov; 24(21):12716-12725. PubMed ID: 32977368
[TBL] [Abstract][Full Text] [Related]
4. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
[TBL] [Abstract][Full Text] [Related]
5. Aloperine alleviates lipopolysaccharide-induced acute lung injury by inhibiting NLRP3 inflammasome activation.
Zeng J; Liu J; Huang JH; Fu SP; Wang XY; Xi C; Cui YR; Qu F
Int Immunopharmacol; 2023 Jul; 120():110142. PubMed ID: 37210910
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal peptide suppresses the NLRP3 inflammasome activation in lipopolysaccharide-induced acute lung injury mice and macrophages.
Zhou Y; Zhang CY; Duan JX; Li Q; Yang HH; Sun CC; Zhang J; Luo XQ; Liu SK
Biomed Pharmacother; 2020 Jan; 121():109596. PubMed ID: 31731193
[TBL] [Abstract][Full Text] [Related]
7. A COX-2/sEH dual inhibitor PTUPB alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting NLRP3 inflammasome activation.
Yang HH; Duan JX; Liu SK; Xiong JB; Guan XX; Zhong WJ; Sun CC; Zhang CY; Luo XQ; Zhang YF; Chen P; Hammock BD; Hwang SH; Jiang JX; Zhou Y; Guan CX
Theranostics; 2020; 10(11):4749-4761. PubMed ID: 32308747
[No Abstract] [Full Text] [Related]
8. Intranasal Application of Budesonide Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Nucleotide-Binding Oligomerization Domain-Like Receptor Family, Pyrin Domain-Containing 3 Inflammasome Activation in Mice.
Dong L; Zhu YH; Liu DX; Li J; Zhao PC; Zhong YP; Chen YQ; Xu W; Zhu ZQ
J Immunol Res; 2019; 2019():7264383. PubMed ID: 30937316
[TBL] [Abstract][Full Text] [Related]
9. Tangeretin attenuates acute lung injury in septic mice by inhibiting ROS-mediated NLRP3 inflammasome activation via regulating PLK1/AMPK/DRP1 signaling axis.
Liu Y; Zhang Y; You G; Zheng D; He Z; Guo W; Antonina K; Shukhrat Z; Ding B; Zan J; Zhang Z
Inflamm Res; 2024 Jan; 73(1):47-63. PubMed ID: 38147126
[TBL] [Abstract][Full Text] [Related]
10. CaMK4 Promotes Acute Lung Injury Through NLRP3 Inflammasome Activation in Type II Alveolar Epithelial Cell.
Zhang T; Li M; Zhao S; Zhou M; Liao H; Wu H; Mo X; Wang H; Guo C; Zhang H; Yang N; Huang Y
Front Immunol; 2022; 13():890710. PubMed ID: 35734175
[TBL] [Abstract][Full Text] [Related]
11. Glycyrrhetinic acid alleviates acute lung injury by PI3K/AKT suppressing macrophagic Nlrp3 inflammasome activation.
Wang K; Zhang Y; Cao Y; Shi Z; Lin Y; Chen Y; Zhao H; Liu X
Biochem Biophys Res Commun; 2020 Nov; 532(4):555-562. PubMed ID: 32900490
[TBL] [Abstract][Full Text] [Related]
12. 6-Gingerol attenuates sepsis-induced acute lung injury by suppressing NLRP3 inflammasome through Nrf2 activation.
Pan Q; Liu P; Wan M
Folia Histochem Cytobiol; 2023; 61(1):68-80. PubMed ID: 36734635
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation.
Jiang L; Zhang L; Kang K; Fei D; Gong R; Cao Y; Pan S; Zhao M; Zhao M
Biomed Pharmacother; 2016 Dec; 84():130-138. PubMed ID: 27643555
[TBL] [Abstract][Full Text] [Related]
14. Epoxyeicosatrienoic acids inhibit the activation of NLRP3 inflammasome in murine macrophages.
Luo XQ; Duan JX; Yang HH; Zhang CY; Sun CC; Guan XX; Xiong JB; Zu C; Tao JH; Zhou Y; Guan CX
J Cell Physiol; 2020 Dec; 235(12):9910-9921. PubMed ID: 32452554
[TBL] [Abstract][Full Text] [Related]
15. Total tanshinones protect against acute lung injury through the PLCγ2/NLRP3 inflammasome signaling pathway.
Li X; Qiu H; Gan J; Liu Z; Yang S; Yuan R; Gao H
J Ethnopharmacol; 2023 Oct; 314():116478. PubMed ID: 37121449
[TBL] [Abstract][Full Text] [Related]
16. RIP3 dependent NLRP3 inflammasome activation is implicated in acute lung injury in mice.
Chen J; Wang S; Fu R; Zhou M; Zhang T; Pan W; Yang N; Huang Y
J Transl Med; 2018 Aug; 16(1):233. PubMed ID: 30126430
[TBL] [Abstract][Full Text] [Related]
17. Nano-chemically Modified Tetracycline-3 (nCMT-3) Attenuates Acute Lung Injury via Blocking sTREM-1 Release and NLRP3 Inflammasome Activation.
Meng Q; Wang X; Guo D; Shi C; Gu R; Ma J; Nieman G; Kollisch-Singule M; Luo J; Cooney RN
Shock; 2022 May; 57(5):749-758. PubMed ID: 35583915
[TBL] [Abstract][Full Text] [Related]
18. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury.
Jiang L; Fei D; Gong R; Yang W; Yu W; Pan S; Zhao M; Zhao M
Inflamm Res; 2016 Nov; 65(11):905-915. PubMed ID: 27412237
[TBL] [Abstract][Full Text] [Related]
19. Implication of mitochondrial ROS-NLRP3 inflammasome axis during two-hit mediated acute lung injury in mice.
Puri G; Naura AS
Free Radic Res; 2022 Jan; 56(1):1-16. PubMed ID: 35129032
[TBL] [Abstract][Full Text] [Related]
20. Dynasore Alleviates LPS-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis.
Shan M; Wan H; Ran L; Ye J; Xie W; Lu J; Hu X; Deng S; Zhang W; Chen M; Wang F; Guo Z
Drug Des Devel Ther; 2024; 18():1369-1384. PubMed ID: 38681210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
